Khloris Biosciences Presents at SITC 2023: Both Allogeneic and Syngeneic induced Pluripotent Stem Cell (iPSC) Vaccines Decrease Tumor Growth and Improve Survival in a Prophylactic Mouse Model of Breast Cancer
Learn more
Khloris Biosciences Presents at SITC 2023: Efficacy and Immunogenicity of Induced Pluripotent Stem Cell (iPSC) Vaccine is Independent of iPSC Viability in a Prophylactic Mouse Model of Breast Cancer
Learn more
Khloris Biosciences presents at SITC 2021: An induced pluripotent stem cell (iPSC) vaccine decreases tumor growth and improves survival in a therapeutic mouse model of colon cancer
Learn more
Khloris Biosciences presents at SITC 2021: An induced pluripotent stem cell (iPSC) vaccine is highly immunogenic and reduces lung metastases in a mouse model of melanoma
Learn more